Company Encyclopedia
View More
name
iShares Core S&P Mid Cap
IJH.US
News
View More

United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing

marketscreener·
US
UTHR
-0.84%
marketscreener·
US
UTHR
-0.84%

United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares

Paul A. Mahon, EVP & General Counsel of United Therapeutics Corporation, reported the disposal of common shares. The full filing is available via the link provided. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. The original content was published by United Therapeutics via EDGAR on December 29, 2025.

Reuters·
US
UTHR
-0.84%
Reuters·
US
UTHR
-0.84%

United Therapeutics President and COO Michael Benkowitz Reports Sale of Common Shares

Michael Benkowitz, President and COO of United Therapeutics Corporation, reported the sale of common shares. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. The original content was published via EDGAR by United Therapeutics Corporation.

Reuters·
US
UTHR
-0.84%
Reuters·
US
UTHR
-0.84%

Lumentum (NASDAQ:LITE) Stock Price Down 6.5% - Here's Why

Lumentum (NASDAQ:LITE) Stock Price Down 6.5% - Should You Sell?

Market Beat·
US
LITE
-4.65%
Market Beat·
US
LITE
-4.65%

Ciena (NYSE:CIEN) CEO Sells $1,587,528.00 in Stock

Ciena Corporation (NYSE:CIEN) CEO Gary Smith sold 6,800 shares of stock for $1,587,528 on December 22nd, reducing his ownership by 1.71%. Post-sale, he holds 391,437 shares valued at approximately $91.38 million. The stock price fell 2.0% to $236.85, with a market cap of $33.36 billion. Ciena reported a quarterly EPS of $0.91, exceeding estimates, and a revenue increase of 20.1% year-over-year. Analysts have a consensus rating of "Moderate Buy" with an average target price of $237.50.

Market Beat·
US
CIEN
-1.11%
Market Beat·
US
CIEN
-1.11%
Posts
View More

ugly after hours

are $orcl earnings really reversing the entire move we saw today from a dovish Powell

the call was bad, really bad

but it shouldn’t be reversing one of the most dovish FOMC’s we’ve had .........

The market attaches a 95% probability to a Fed funds rate cut of 25bp on Wednesday, to 3.5-3.75%. The market expects two additional 25bp rate cuts in 2026 in March and June. To appease inflation haw...

  • 0
© 2025 Longbridge｜Disclaimer